Evidence map›Paper›PMID 19966808›Full record

ArticleNature methods2010

Floxin, a resource for genetically engineering mouse ESCs.

Veena Singla, Julie Hunkapiller, Nicole Santos, Allen D Seol, Andrew R Norman, Paul Wakenight, William C Skarnes, Jeremy F Reiter

Open access · greenAbstract read
In one paragraph

Article in Nature methods, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Hedgehog signaling drives medulloblastoma growth via CDK6.The Journal of clinical investigation · 2018
    Article
  5. Article
  6. Article
  7. Two-Pore Channels: Lessons from Mutant Mouse Models.Messenger (Los Angeles, Calif. : Print) · 2015
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Gene trap mutagenesis in the mouse.Methods in enzymology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Veena SinglaDepartment of Biochemistry and Biophysics, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.
Julie Hunkapiller
Nicole Santos
Allen D Seol
Andrew R Norman
Paul Wakenight
William C Skarnes
Jeremy F Reiter
University of California, San Francisco · USStanford University · USUniversity of Chicago · USWellcome Sanger Institute · GB

Funding

Hedgehog signaling at the cell's antenna: Smoothened and the primary ciliumR01AR054396 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jeremy F Reiter · 2007 to 2026
$9.0M
NIAMS NIH HHS R01 AR054396NIAMS NIH HHS R01AR054396
6 · The paper itself

Abstract

We describe a method for the highly efficient and precise targeted modification of gene trap loci in mouse embryonic stem cells (ESCs). Through the Floxin method, gene trap mutations were reverted and new DNA sequences inserted using Cre recombinase and a shuttle vector, pFloxin. Floxin technology is applicable to the existing collection of 24,149 compatible gene trap cell lines, which should enable high-throughput modification of many genes in mouse ESCs.

Indexed as

AllelesAnimalsAttachment Sites, MicrobiologicalBase SequenceCell LineEmbryonic Stem CellsEnhancer Elements, GeneticExpressed Sequence TagsGenetic EngineeringGenetic MarkersGenetic VectorsIntegrasesMiceMice, TransgenicMutationCre recombinaseGenetic MarkersIntegrases

Identifiers

PMID19966808
PMCPMC2895430
OpenAlexW2038801379

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.